Thorium dioxide (Thorotrast)

Acute myeloid leukaemia - Thorium dioxide (Thorotrast) Factor

Last reviewed for CCPS 08 January 2007.

Preliminary questions [36771]

36772 there is some evidence that thorium dioxide (Thorotrast) may be a factor in the development of the condition under consideration.

36773 the veteran has received thorium dioxide (Thorotrast) at some time.

36774 — the veteran has established the causal connection between thorium dioxide (Thorotrast) and VEA service for the clinical onset of acute myeloid leukaemia.

36776 — the veteran has established the causal connection between thorium dioxide (Thorotrast) and eligible service for the clinical onset of acute myeloid leukaemia.

or

36775 — the veteran has established the causal connection between thorium dioxide (Thorotrast) and operational service for the clinical onset of acute myeloid leukaemia.

Clinical onset and operational service [36775]

36777 the veteran received thorium dioxide (Thorotrast) at least one year before the clinical onset of the condition under consideration.

36779 — the veteran received thorium dioxide (Thorotrast) for an illness or injury which is identifiable.

36780

the veteran received thorium dioxide (Thorotrast) at least one year before the clinical onset of the condition under consideration for an illness or injury which is identifiable.

36782 — the identified illness or injury, for which the veteran received thorium dioxide (Thorotrast), is causally related to operational service.

Clinical onset and eligible service [36776]

36778

the veteran received thorium dioxide (Thorotrast) at least two years before the clinical onset of the condition under consideration.

36779 — the veteran received thorium dioxide (Thorotrast) for an illness or injury which is identifiable.

36781

the veteran received thorium dioxide (Thorotrast) at least two years before the clinical onset of the condition under consideration for an illness or injury which is identifiable.

36783 — the identified illness or injury, for which the veteran received thorium dioxide (Thorotrast), is causally related to eligible service.